Pathologists get to the bottom of AML subtypes December 12, 2019 -- Whole genome and transcriptome sequencing enabled more precise assessment of acute myeloid leukemia (AML) and myelodysplastic syndromes, shedding light on their true genetic natures, in a new study presented at the American Society of Hematology annual meeting in Orlando, FL. Discuss
AbbVie to deploy Adaptive's clonoSeq test in myeloma trials December 9, 2019 -- AbbVie is set to use Adaptive Biotechnologies' clonoSeq next-generation sequencing test for measuring minimal residual disease as a marker of treatment response across its trials of the B-cell lymphoma 2 inhibiting drug venetoclax (Venclexta) in multiple myeloma.
Low white blood cell count warns of bad outcomes December 3, 2019 -- Lymphopenia, or low white blood cell count, is an independent risk factor for shorter survival, according to a large new study published in JAMA Network Open on December 2. This information is readily available through routine complete blood count testing, so those at risk can be easily identified, study investigators noted. Discuss
Hematology thrives with decentralized approaches November 21, 2019 -- Hematology will remain the second-largest volume of global IVD procedures, with the number of tests increasing 5.3% per year to nearly 6.7 billion in 2024, according to Bruce Carlson, publisher of Kalorama Information, who charts the rise of hematology tests. Discuss
Ortho Sera extended blood typing clears FDA October 18, 2019 -- Ortho Clinical Diagnostics has announced the U.S. Food and Drug Administration (FDA) clearance of its Ortho Sera ID-Micro Typing System (MTS) extended antigen phenotyping in blood transfusion products, for use on the company's Ortho Vision analyzer.
Blood centers claim FDA safety rules threaten patient access October 4, 2019 -- The U.S. Food and Drug Administration (FDA) should continue to assess the effects of new guidance for controlling the risk of bacterial contamination of platelets in blood collection establishments and transfusion services, according to America's Blood Centers, a large network of community-based, independent blood programs in North America.
Sysmex, LabCorp extend hematology automation pact September 26, 2019 -- Sysmex America and LabCorp announced they are extending their hematology automation agreement. Sysmex America is providing LabCorp Diagnostics' primary reference laboratories with Sysmex's upgraded XN series technology.